bioAffinity Technologies ...

0.28
0.00 (1.30%)
At close: Mar 24, 2025, 3:59 PM
0.30
7.53%
After-hours: Mar 24, 2025, 05:28 PM EDT

bioAffinity Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue 2.53M 4.8K n/a n/a n/a
Cost of Revenue 1.74M 467.00 4.82K 22.24K 40.28K
Gross Profit 791.62K 4.34K -4.82K -22.24K -40.28K
Operating Income -7.97M -4.01M -2.21M -2.6M -3.09M
Interest Income 122.13K 46.71K 424.00 1.07K 2.78K
Pretax Income -7.92M -8.15M -6.32M -7.27M -3.3M
Net Income -7.94M -8.15M -6.33M -7.27M -3.31M
Selling & General & Admin 6.79M 2.73M 880.77K 994.34K 1.2M
Research & Development 1.72M 1.29M 1.33M 1.61M 1.85M
Other Expenses 249.59K -1.87M 724.93K -4.28M n/a
Operating Expenses 8.76M 4.02M 2.21M 2.6M 3.05M
Interest Expense 37.13K 2.53M 1M 382.17K 214.83K
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 10.51M 4.02M 2.21M 2.6M 3.09M
Income Tax 20.99K 2.46K 1.95K 2.75K 3.2K
Shares Outstanding (Basic) 8.75M 4.5M 7.38M 7.38M 7.38M
Shares Outstanding (Diluted) 8.75M 4.5M 7.38M 7.38M 7.38M
EPS (Basic) -0.91 -1.81 -0.86 -0.99 -0.45
EPS (Diluted) -0.91 -1.81 -0.86 -0.99 -0.45
EBITDA -7.63M -5.61M -2.2M -6.86M -3.05M
Depreciation & Amortization 249.59K 10.18K 4.82K 22.24K 40.28K